PW Medtech Group Ltd. (HK:1358) has released an update.
PW Medtech Group Ltd. is set to enhance its strategic position by spinning off its subsidiary, Sichuan Ruijian Medical, aiming for a separate quotation on NEEQS and a potential subsequent listing on the Beijing Stock Exchange. The move, which has received preliminary approval from the Hong Kong Stock Exchange, is designed to capture growth in China’s blood purification market, improve corporate governance, and provide clearer business and financial insight to investors. The spin-off is expected to raise Sichuan Ruijian Medical’s profile, increase sales, market share, and access to capital, without issuing new shares for the initial NEEQS Quotation.
For further insights into HK:1358 stock, check out TipRanks’ Stock Analysis page.
